Effect of tafamidis on cardiac function in patients with transthyretin amyloid cardiomyopathy: a post hoc analysis of the ATTR-ACT randomized clinical trial
SJ Shah, N Fine, P Garcia-Pavia, AL Klein… - JAMA …, 2024 - jamanetwork.com
Importance Tafamidis has been shown to improve survival in patients with transthyretin
amyloid cardiomyopathy (ATTR-CM) compared with placebo. However, its effect on cardiac …
amyloid cardiomyopathy (ATTR-CM) compared with placebo. However, its effect on cardiac …
Improving fairness in the prediction of heart failure length of stay and mortality by integrating social determinants of health
Background: Machine learning (ML) approaches have been broadly applied to the
prediction of length of stay and mortality in hospitalized patients. ML may also reduce …
prediction of length of stay and mortality in hospitalized patients. ML may also reduce …
Differential diagnosis of suspected chronic obstructive pulmonary disease exacerbations in the acute care setting: best practice
Patients with chronic obstructive pulmonary disease (COPD) may suffer from acute episodes
of worsening dyspnea, often associated with increased cough, sputum, and/or sputum …
of worsening dyspnea, often associated with increased cough, sputum, and/or sputum …
Using deep-learning algorithms to simultaneously identify right and left ventricular dysfunction from the electrocardiogram
Objectives This study sought to develop DL models capable of comprehensively quantifying
left and right ventricular dysfunction from ECG data in a large, diverse population …
left and right ventricular dysfunction from ECG data in a large, diverse population …
Diagnostic value of sST2 in cardiovascular diseases: a systematic review and meta-analysis
T Zhang, C Xu, R Zhao, Z Cao - Frontiers in cardiovascular medicine, 2021 - frontiersin.org
Biomarkers such as B-type natriuretic peptide (BNP), N-terminal pro-BNP (NT-proBNP),
cardiac troponin (cTn), and CK-MB contribute significantly to the diagnosis of cardiovascular …
cardiac troponin (cTn), and CK-MB contribute significantly to the diagnosis of cardiovascular …
Novel oxidative stress biomarkers with risk prognosis values in heart failure
Oxidative stress (OS) is mediated by reactive oxygen species (ROS), which in
cardiovascular and other disease states, damage DNA, lipids, proteins, other cellular and …
cardiovascular and other disease states, damage DNA, lipids, proteins, other cellular and …
Safety of continuing mineralocorticoid receptor antagonist treatment in patients with heart failure with reduced ejection fraction and severe kidney disease: Data from …
F Guidetti, LH Lund, L Benson, C Hage… - European Journal of …, 2023 - Wiley Online Library
ABSTRACT Aims Mineralocorticoid receptor antagonists (MRAs) improve outcomes in heart
failure with reduced ejection fraction (HFrEF) but remain underused and are often …
failure with reduced ejection fraction (HFrEF) but remain underused and are often …
Heart failure diagnosis in the general community–Who, how and when? A clinical consensus statement of the Heart Failure Association (HFA) of the European Society …
KF Docherty, CSP Lam, A Rakisheva… - European Journal of …, 2023 - Wiley Online Library
A significant proportion of patients experience delays in the diagnosis of heart failure due to
the non‐specific signs and symptoms of the syndrome. Diagnostic tools such as …
the non‐specific signs and symptoms of the syndrome. Diagnostic tools such as …
Effects of exercise on heart failure with preserved ejection fraction: an updated review of literature
G Crisci, M De Luca, R D'Assante, B Ranieri… - Journal of …, 2022 - mdpi.com
Heart failure with preserved ejection fraction (HFpEF) represents the most common HF
phenotype of patients aged> 65 years, with an incidence and a prevalence that are …
phenotype of patients aged> 65 years, with an incidence and a prevalence that are …
Patient and Management Variables Associated With Survival After Postcardiotomy Extracorporeal Membrane Oxygenation in Adults: The PELS‐1 Multicenter Cohort …
Background Extracorporeal membrane oxygenation (ECMO) has been increasingly used for
postcardiotomy cardiogenic shock, but without a concomitant reduction in observed in …
postcardiotomy cardiogenic shock, but without a concomitant reduction in observed in …